This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yoshiki Sumitomo: Innovator in Antibody Development
Introduction
Yoshiki Sumitomo is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions. His work focuses on advancing medical treatments through the creation of novel antibodies.
Latest Patents
Yoshiki Sumitomo holds a patent for a bispecific antibody that binds to CD40 and GPC3. This innovative approach has the potential to enhance therapeutic efficacy in treating various diseases, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Sumitomo is associated with Kyowa Kirin Co., Ltd., a leading biopharmaceutical company. His role at the company has allowed him to leverage his expertise in antibody engineering and contribute to groundbreaking research and development initiatives.
Collaborations
Yoshiki Sumitomo has collaborated with Masayuki Kai, a fellow researcher, to further enhance the impact of their work in the field of antibody development. Their partnership exemplifies the importance of teamwork in driving innovation.
Conclusion
Yoshiki Sumitomo's contributions to the field of biotechnology, particularly through his patent on bispecific antibodies, highlight his role as a key innovator. His work continues to pave the way for advancements in medical treatments, making a significant impact on healthcare.